Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | — | +81.9K | 36.2K | New | — |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Daniell Richard | EVP, European Commercial | S - Sale+OE | $7.44 | -59.0K | 20.3K | -74% | -$438.5K |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | $0.00 | -81.9K | 67.7K | -55% | $0 |
| D | 2022-03-08 | 2022-03-04 | TEVA | Daniell Richard | EVP, European Commercial | A - Grant | $0.00 | +134.0K | 134.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-03-05 | M | A | 22,576 | — | 65,758 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2022-03-07 | S | D | 22,576 | $7.37 | 43,182 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Ordinary Shares | 2022-03-04 | S | D | 20,456 | $7.48 | 43,182 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F5) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Ordinary Shares | 2022-03-04 | M | A | 43,358 | — | 63,638 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 5 | Common | Ordinary Shares | 2022-03-04 | S | D | 15,920 | $7.48 | 20,280 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Ordinary Shares | 2022-03-04 | M | A | 15,920 | — | 36,200 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 7 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 15,920 | $0.00 | 15,921 | D | — · — to — | 15,920 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F7) Restricted share units were granted on March 4, 2019, with 15,920 having vested on each of March 4, 2021 and March 4, 2022, and 15,921 vesting on March 4, 2023. |
| 8 | Derivative | Restricted Share Units | 2022-03-04 | A | A | 134,048 | $0.00 | 134,048 | D | — · — to — | 134,048 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F9) Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026. |
| 9 | Derivative | Restricted Share Units | 2022-03-04 | M | D | 43,358 | $0.00 | 0 | D | — · — to — | 43,358 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F8) Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022. |
| 10 | Derivative | Restricted Share Units | 2022-03-05 | M | D | 22,576 | $0.00 | 67,728 | D | — · — to — | 22,576 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F10) Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025. |